author-photo

Filippo Gustavo Dall’Olio

University of Bologna

9

Papers

132

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-A systematic review and meta-analysis of real world data.

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (38)
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (48)
The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma—Letter

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
MA03.03 CEA and CYFRA 21-1 as Prognostic Biomarkers of Benefit from Nivolumab and as a Tool in Treatment Monitoring in Advanced NSCLC

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical significance of ROS1 5’ deletions in non-small cell lung cancer

2019 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (5)